Chlorpromazine Versus Atypical Antipsychotic Drugs for Schizophrenia

doi 10.1002/14651858.cd010631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

John Wiley & Sons, Ltd

Related search

Metabolomic Mapping of Atypical Antipsychotic Effects in Schizophrenia

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2007English

Comparative Cytochrome P450In VitroInhibition by Atypical Antipsychotic Drugs

ISRN Pharmacology
2013English

Specific Effects of Antipsychotic Chlorpromazine on Glutamatergic Ionotropic Mechanisms. Novel Targets for Treatment Schizophrenia

International Journal of Brain Disorders and Treatment
2017English

Risk of Death Associated With the Use of Conventional Versus Atypical Antipsychotic Drugs Among Elderly Patients

CMAJ
Medicine
2007English

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2017English

Clinical Efficacy of Antipsychotic Drugs in the Treatment of Schizophrenia

Journal of Cytology & Histology
2014English

Pharmacoeconomic Comparison of Ziprasidone With Other Atypical Oral Antipsychotic Agents in Schizophrenia

Farmeconomia. Health economics and therapeutic pathways
2011English

Review: New Generation Antipsychotic Drugs May Reduce Relapse Rates More Effectively Than Conventional Antipsychotic Drugs in People With Schizophrenia

Evidence-Based Mental Health
PsychiatryMental Health
2004English

Antipsychotic Monotherapy and Polypharmacy in the Naturalistic Treatment of Schizophrenia With Atypical Antipsychotics

BMC Psychiatry
PsychiatryMental Health
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy